Fusion Pharmaceuticals, a member of the AstraZeneca Group, is a clinical stage oncology company focused on developing next generation radioconjugates (RCs) as precision medicines. Fusion connects alpha particle emitting isotopes to various targeting molecules to selectively deliver the alpha emitting…